Mark Hartman

Mark Hartman is a Vice President in Medical focusing on NASH/Obesity at Eli Lilly and Company. They are an endocrinologist by training, having transitioned from a 10-year academic career at the University of Virginia Medical School, where they engaged in patient care and NIH-funded clinical research. Since joining Eli Lilly in 1998, Mark has held various management roles, overseeing teams in medical affairs, clinical development, and risk management. Mark enjoys collaborating with cross-functional teams to tackle complex health challenges that enhance patient outcomes.